Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Biasco

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Plos One|August 23, 2012
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutationsGiovanni Brandi, Simona Tavolari, Francesco De Rosa, et al.
The American Journal of Gastroenterology|June 20, 2006
Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosaGiovanni Brandi, Bruno Biavati, Carlo Calabrese, et al.
Future Oncology (London, England)|May 7, 2025
Are we doing enough to treat cancer pain? The urgent need for action in oncology practiceMassimo Aglietta, Berardi Rossana, Guido Biasco, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2025
Assessment and monitoring by Integrated Palliative care Outcome Scale: an observational study on cancer patients at homeRita Ostan, Giuseppe Gambino, Luca Franchini, et al.
Journal of Chemotherapy (Florence, Italy)|June 24, 2017
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasmsGiovanni Brandi, Marco Paragona, Davide Campana, et al.
Future Oncology (London, England)|July 12, 2017
Postsorafenib systemic treatments for hepatocellular carcinoma: questions and opportunities after the regorafenib trialFrancesco Tovoli, Stefania De Lorenzo, Maria Aurelia Barbera, et al.
BMC Medical Genetics|September 30, 2015
SDHC methylation in gastrointestinal stromal tumors (GIST): a case reportMilena Urbini, Annalisa Astolfi, Valentina Indio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2013
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?Giovanni Brandi, Francesco de Rosa, Laura Calzà, et al.
Palliative Medicine|March 26, 2014
The 'surprise' question in advanced cancer patients: A prospective study among general practitionersMatteo Moroni, Donato Zocchi, Deborah Bolognesi, et al.
Melanoma Research|August 12, 2004
Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma IntergroupRuggero Ridolfi, Antonella Romanini, Vanna Chiarion Sileni, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Plos One|August 23, 2012
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutationsGiovanni Brandi, Simona Tavolari, Francesco De Rosa, et al.
The American Journal of Gastroenterology|June 20, 2006
Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosaGiovanni Brandi, Bruno Biavati, Carlo Calabrese, et al.
Future Oncology (London, England)|May 7, 2025
Are we doing enough to treat cancer pain? The urgent need for action in oncology practiceMassimo Aglietta, Berardi Rossana, Guido Biasco, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2025
Assessment and monitoring by Integrated Palliative care Outcome Scale: an observational study on cancer patients at homeRita Ostan, Giuseppe Gambino, Luca Franchini, et al.
Journal of Chemotherapy (Florence, Italy)|June 24, 2017
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasmsGiovanni Brandi, Marco Paragona, Davide Campana, et al.
Future Oncology (London, England)|July 12, 2017
Postsorafenib systemic treatments for hepatocellular carcinoma: questions and opportunities after the regorafenib trialFrancesco Tovoli, Stefania De Lorenzo, Maria Aurelia Barbera, et al.
BMC Medical Genetics|September 30, 2015
SDHC methylation in gastrointestinal stromal tumors (GIST): a case reportMilena Urbini, Annalisa Astolfi, Valentina Indio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2013
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?Giovanni Brandi, Francesco de Rosa, Laura Calzà, et al.
Palliative Medicine|March 26, 2014
The 'surprise' question in advanced cancer patients: A prospective study among general practitionersMatteo Moroni, Donato Zocchi, Deborah Bolognesi, et al.
Melanoma Research|August 12, 2004
Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma IntergroupRuggero Ridolfi, Antonella Romanini, Vanna Chiarion Sileni, et al.
Pageof 17